{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:38:36Z","timestamp":1773837516464,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.radonc.2016.12.003","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T14:39:37Z","timestamp":1482417577000},"page":"452-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk Stage I endometrial cancer"],"prefix":"10.1016","volume":"122","author":[{"given":"Matthew M.","family":"Harkenrider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec M.","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kliethermes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.12.003_b0005","unstructured":"World Cancer Research Fund International Worldwide Data. http:\/\/www.wcrf.org\/int\/cancer-facts-figures\/worldwide-data. Accessed 22 October 2016."},{"key":"10.1016\/j.radonc.2016.12.003_b0010","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.radonc.2016.12.003_b0015","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.12.003_b0020","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.12.003_b0025","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2016.12.003_b0030","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.12.003_b0035","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2013a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.12.003_b0040","first-page":"3403","article-title":"Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group","volume":"159","author":"Poulsen","year":"1997","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.radonc.2016.12.003_b0045","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/IGC.0b013e318229264e","article-title":"Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: the Danish Endometrial Cancer Study (DEMCA)","volume":"21","author":"Bertelsen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.radonc.2016.12.003_b0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.295.4.389","article-title":"Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma","volume":"295","author":"Lee","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2016.12.003_b0055","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.ijrobp.2011.03.054","article-title":"The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer","volume":"82","author":"Chino","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.12.003_b0060","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0000000000000273","article-title":"Stage I and II endometrial adenocarcinoma: analysis of 2009 FIGO staging revision and impact on survival by adjuvant therapy","author":"Cahan","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.12.003_b0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/cncr.21592","article-title":"Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee","volume":"106","author":"Newman","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.12.003_b0070","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.12.003_b0075","series-title":"Modeling survival data in medical research","article-title":"Frailty models","author":"Collett","year":"2015"},{"key":"10.1016\/j.radonc.2016.12.003_b0080","series-title":"Landmarking. Handbook of survival analysis","author":"Putter","year":"2014"},{"key":"10.1016\/j.radonc.2016.12.003_b0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the Cox model with cumulative sums of martingale-based residuals","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"key":"10.1016\/j.radonc.2016.12.003_b0090","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2013a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2016.12.003_b0095","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.12.003_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.12.003_b0105","article-title":"Adjuvant radiotherapy for stage I endometrial cancer","volume":"4","author":"Kong","year":"2012"},{"key":"10.1016\/j.radonc.2016.12.003_b0110","unstructured":"About the SEER Program. http:\/\/seer.cancer.gov\/about\/. Accessed 26 June 2016."},{"key":"10.1016\/j.radonc.2016.12.003_b0115","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2014.12.036","article-title":"The role of vaginal cuff brachytherapy in endometrial cancer","volume":"136","author":"Harkenrider","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.radonc.2016.12.003_b0120","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/bjc.2014.322","article-title":"Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians","volume":"111","author":"Kunneman","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2016.12.003_b0125","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401634419X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401634419X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T20:28:24Z","timestamp":1749846504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781401634419X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S016781401634419X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.12.003","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk Stage I endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}